NIH Director's New Innovator Award Program Details and Process
Learn about the NIH Director's New Innovator Award Program, launched in 2007, aimed at exceptionally creative early-stage investigators. Explore the application details, scientific areas, peer-review process, and selection of finalists for this prestigious award. Gain insights into the bold and innovative research supported with a grant of $1.5 million over five years.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
NIH Directors New Innovator Award (DP2) Srikanth Ranganathan, PhD Scientific Review Officer, New Innovator Award Review Musculoskeletal, Oral and Skin Sciences IRG, CSR, NIH CSR Advisory Council Meeting September 24, 2018
NIH Director's New Innovator Award Program Logo Program Details Launched in 2007: Minimum of 33-35 awards Exceptionally creative Early Stage Investigators (No Multi-PI applications) Bold and highly innovative research with significant impact $1.5 million in direct costs for a 5-year grant 500-600 applications each year
The NIH Director's New Innovator award program logo New Innovator Award Review and Funding Proc
NIH Director's New Innovator Award Program Logo Application Details
The NIH Director New Innovator award program logo Scientific Areas 1. Behavioral and Social Science (BBS) 2. Chemical Biology (CB) 3. Clinical and Translational Research (CTR) 4. Infectious Disease and Immunology (IDI) 5. Instrumentation and Engineering (IE) 6. Molecular and Cellular Biology (MCB) 7. Neuroscience (NS) 8. High Throughput and Integrative Biology (HIB) 9. Bioinformatics and Computational Biology (BCB)
The NIH Director's New Innovator Award Program logo Peer-Review Process: Stage 1 (Mail Reviews) ~200 Mail Reviewers Up to 10 Assignments / Rev 3 Reviewers / Application Three Criteria and an Overall Impact Score (1-9) Importance and Potential Impact of the Scientific Problem Novelty / Innovativeness of Approach Creative Potential of ESI Overall Impact Paragraph
NIH Director's New Innovator award program logo Selection of Finalists Rank order list of the Mail reviewers Overall Impact Scores Any application with a score better than a set threshold is an automatic finalist An unbiased selection of applications by the editorial panelists from the rest of the applications (they are provided access to the overall impact scores and the critiques) The editorial panelists do not need to provide a justification About 20% of applications selected for Stage 2
NIH Director's New Innovator Award Program logo Stage 2: Final Meeting 26-27 panelists Experts with broad scientific understanding ~110 applications (All discussed) 2 days 3 Discussants / Application First 2 discussants are generally covering the science areas of the application Scoring is focused on Impact & Innovation Release of final scores and Summary statements
NIH Director New Innovator Award Program Logo Thank You Rajiv Kumar, PhD Support Staff (MOSS IRG) Chief, MOSS IRG Ms. Lynda Robinson Ms. Lauren Nazzel Ms. Beverly Cleveland Ms. Latonya Carter
NIH Director's New Innovator Award Program logo Sampling of Awardees
